Monitor the May 5 earnings call for updated full-year guidance and clarity on China reimbursement impact; the stock may face continued pressure until there is evidence of respiratory season recovery or stabilization in China.
Price Chart
Executive Summary
QuidelOrtho reported preliminary Q1 2026 revenue of $615–620 million, below consensus of $670.7 million, citing a weaker respiratory season, China reimbursement uncertainty, and Middle East disruptions. The company reaffirmed the low end of its full-year guidance remains achievable.
Key Financial Metrics
Key Facts
- Preliminary Q1 2026 revenue expected between $615M and $620M
- Consensus revenue estimate was $670.7M
- Revenue shortfall driven by weaker respiratory season (U.S. flu visits down ~30% YoY), slower China distributor sales due to proposed NHSA reimbursement cuts, and delayed EMEA orders from Middle East conflict
- Company reaffirmed the low end of its full-year 2026 guidance is still achievable
- Free cash flow expected to be negative in the range of $(65) to $(70) million for Q1 2026
Financial Impact
Revenue miss of $50.7–$55.7 million, or approximately 8.4–9.3% below consensus
Risk Factors
- Further downward revision to full-year 2026 guidance
- Prolonged weakness in respiratory testing demand
- Negative impact from China NHSA reimbursement rate reductions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001906324-26-000013 |
| Document: qdel41520268-kitem991.htm | 0001906324-26-000013 |
| Document: 0001906324-26-000013-index-headers.html | 0001906324-26-000013 |
| Document: 0001906324-26-000013-index.html | 0001906324-26-000013 |
| Document: 0001906324-26-000013.txt | 0001906324-26-000013 |
| 8-K Data (Synthetic) | 0001906324-26-000013 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | SC 13G/A | $12.31 $13.87 | ▲ +12.67% | ▲ +13.65% | $13.59 (+10.40%) |
Sep 23, 2026 4w ago | 8-K | $10.69 $10.38 | ▲ +2.90% | ▲ +2.48% | $13.59 (−27.13%) |
Jul 15, 2026 14w ago | 3 | $18.24 $16.58 | ▼ −9.10% | ▼ −7.43% | $13.59 (−25.49%) |
Jun 23, 2026 18w ago | 8-K | $12.21 $18.18 | ▲ +48.89% | ▲ +47.19% | $13.59 (+11.30%) |
Jun 11, 2026 19w ago | Institutional Cluster | $14.13 $13.67 | ▼ −3.26% | ▼ −3.93% | $13.59 (−3.82%) |
Jun 11, 2026 19w ago | Institutional Cluster | $14.09 $13.13 | ▼ −6.81% | ▼ −7.25% | $13.59 (−3.55%) |
Apr 27, 2026 26w ago | DEFA14A | $12.02 $12.42 | ▲ +3.33% | ▲ +1.64% | $13.59 (+13.06%) |
Apr 15, 2026 27w ago | 8-K | $12.69 $11.24 | ▲ +11.43% | ▲ +12.41% | $13.59 (−7.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers